[{"quiz_id": "20251201T041413890Z_grok-4-0709_seed125", "question_id": "20251201T041413890Z_grok-4-0709_seed125-001", "question": "A 45-year-old man with a history of alcoholic cirrhosis presents to the ICU with massive upper gastrointestinal bleeding. Despite endoscopic intervention and octreotide infusion, bleeding persists, and he develops hemodynamic instability. Transjugular intrahepatic portosystemic shunt (TIPS) is considered, but imaging reveals a rare anatomical variant. What is the most appropriate next step in management?", "options": ["Proceed with TIPS using a covered stent to mitigate risks", "Initiate balloon tamponade with a Sengstaken-Blakemore tube", "Administer terlipressin as an alternative vasoconstrictor", "Perform urgent surgical portocaval shunt", "Refer for angiographic embolization of the coronary vein"], "answer": "E", "answer_index": 4, "explanation": "In persistent variceal bleeding with anatomical variants precluding TIPS, angiographic embolization targets specific bleeding vessels like the coronary vein, offering a less invasive option. TIPS is contraindicated due to the variant, while surgical shunts carry high mortality in unstable patients. Terlipressin and balloon tamponade are temporizing but not definitive here.", "generator_model": "grok-4-0709", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: U (Underspecified). Verdict: Not uniquely determinable. The stem states a 'rare anatomical variant' precluding TIPS but does not specify the variant, which is critical for determining the next step. Without knowing the specific anatomy (e.g., portal vein thrombosis, hepatic vein anomaly), the defensibility of angiographic embolization (E) versus a surgical shunt (D) or other options cannot be assessed from the vignette alone. The keyed answer (E) relies on an unstated assumption that the coronary vein is the accessible and appropriate target. Medical accuracy is reasonable for the options presented, but the logic fails due to missing specification. Minimal fix: Specify the anatomical variant (e.g., 'portal vein thrombosis') in the stem to justify the unique best answer.\",\n  \"logical_false_reason\": \"U\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \"4\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (Underspecified). Verdict: Not uniquely determinable. The stem states a 'rare anatomical variant' precluding TIPS but does not specify the variant, which is critical for determining the next step. Without knowing the specific anatomy (e.g., portal vein thrombosis, hepatic vein anomaly), the defensibility of angiographic embolization (E) versus a surgical shunt (D) or other options cannot be assessed from the vignette alone. The keyed answer (E) relies on an unstated assumption that the coronary vein is the accessible and appropriate target. Medical accuracy is reasonable for the options presented, but the logic fails due to missing specification. Minimal fix: Specify the anatomical variant (e.g., 'portal vein thrombosis') in the stem to justify the unique best answer.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed125", "question_id": "20251201T041413890Z_grok-4-0709_seed125-002", "question": "A 62-year-old woman with metastatic breast cancer on paclitaxel develops acute dyspnea and hypoxemia. CT angiography shows no pulmonary embolism, but echocardiography reveals right ventricular strain. Bone marrow biopsy confirms tumor infiltration. What is the most likely diagnosis?", "options": ["Paclitaxel-induced pneumonitis", "Tumor microembolism syndrome", "Lymphangitic carcinomatosis", "Chemotherapy-associated pulmonary veno-occlusive disease", "Metastatic tumor thrombus in pulmonary arteries"], "answer": "B", "answer_index": 1, "explanation": "Tumor microembolism syndrome occurs when tumor cells embolize to pulmonary vasculature, causing right heart strain without macroscopic emboli, fitting this presentation in metastatic cancer. Lymphangitic carcinomatosis typically shows interstitial patterns on imaging, while paclitaxel pneumonitis is inflammatory. Veno-occlusive disease is more associated with stem cell transplant regimens.", "generator_model": "grok-4-0709", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: M (Multiple answers defensible). Verdict on keyed answer: Not uniquely determinable. Key stem clues: metastatic breast cancer on paclitaxel, acute dyspnea/hypoxemia, CT angiography negative for PE, echocardiography shows RV strain, bone marrow biopsy shows tumor infiltration. The findings of acute RV strain without macroscopic PE in a metastatic cancer patient can fit both tumor microembolism (B) and lymphangitic carcinomatosis (C), as both can present acutely and cause hypoxemia and RV dysfunction; the provided imaging detail (CT angiography) is insufficient to discriminate, as neither typically shows large emboli. The bone marrow finding is a red herring, not directly causative. Main logical issue: Option C is a strong alternative; the stem lacks a discriminating feature (e.g., characteristic CT findings like septal thickening) to make B uniquely best. Main medical accuracy issue: Minor—lymphangitic spread can cause acute symptoms and RV strain, though often subacute. Minimal fix: Specify CT findings (e.g., 'CT shows no PE but reveals smooth interlobular septal thickening') to favor C, or specify 'CT shows no parenchymal abnormalities' to favor B.\",\n    \"logical_false_reason\": \"M\",\n    \"logical_validity\": false,\n    \"medical_accuracy_score\":  \t\n  \"4\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict on keyed answer: Not uniquely determinable. Key stem clues: metastatic breast cancer on paclitaxel, acute dyspnea/hypoxemia, CT angiography negative for PE, echocardiography shows RV strain, bone marrow biopsy shows tumor infiltration. The findings of acute RV strain without macroscopic PE in a metastatic cancer patient can fit both tumor microembolism (B) and lymphangitic carcinomatosis (C), as both can present acutely and cause hypoxemia and RV dysfunction; the provided imaging detail (CT angiography) is insufficient to discriminate, as neither typically shows large emboli. The bone marrow finding is a red herring, not directly causative. Main logical issue: Option C is a strong alternative; the stem lacks a discriminating feature (e.g., characteristic CT findings like septal thickening) to make B uniquely best. Main medical accuracy issue: Minor—lymphangitic spread can cause acute symptoms and RV strain, though often subacute. Minimal fix: Specify CT findings (e.g., 'CT shows no PE but reveals smooth interlobular septal thickening') to favor C, or specify 'CT shows no parenchymal abnormalities' to favor B.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed125", "question_id": "20251201T041413890Z_grok-4-0709_seed125-003", "question": "A 28-year-old man presents to the emergency department with severe headache, vomiting, and photophobia after a recent hiking trip. CSF analysis shows lymphocytic pleocytosis, elevated protein, and normal glucose. PCR for common viruses is negative, but serology reveals antibodies to a rare pathogen. What is the most appropriate initial management?", "options": ["Intravenous acyclovir for presumed herpes encephalitis", "Empiric antibiotics for bacterial meningitis", "Supportive care with close monitoring", "Corticosteroids to reduce inflammation", "Antifungal therapy targeting endemic mycoses"], "answer": "C", "answer_index": 2, "explanation": "This presentation suggests lymphocytic meningitis from a rare arbovirus like Jamestown Canyon virus, where supportive care is the mainstay as no specific antiviral exists. Acyclovir is for herpes, unnecessary here with negative PCR. Antibiotics are for bacterial etiologies, ruled out by CSF profile.", "generator_model": "grok-4-0709", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: acute meningitis syndrome after hiking (exposure risk), CSF lymphocytic pleocytosis with normal glucose and negative viral PCR, serology positive for a rare pathogen. This profile strongly suggests a viral (likely arboviral) meningitis, for which specific antiviral therapy is not available. The keyed answer (C, supportive care) aligns with standard management of suspected viral meningitis when bacterial and herpes simplex etiologies are not supported. The alternatives are less appropriate: A (acyclovir) is not indicated with negative HSV PCR; B (antibiotics) is not indicated with a lymphocytic, normal glucose CSF; D (corticosteroids) is not standard initial management for viral meningitis; E (antifungals) is not indicated without specific fungal risk factors. The item is logically valid and medically accurate. Minimal fix: None required; the item is sound as written.\",\n    \"logical_false_reason\": \"T\",\n    \"logical_validity\": true,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 1051)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed125", "question_id": "20251201T041413890Z_grok-4-0709_seed125-004", "question": "A 7-year-old boy with autism spectrum disorder presents with recurrent episodes of staring spells and facial twitching. EEG shows multifocal epileptiform discharges, and MRI reveals subtle cortical dysplasia. Genetic testing identifies a de novo mutation. What is the most effective first-line therapy?", "options": ["Valproic acid for broad-spectrum coverage", "Levetiracetam to minimize behavioral side effects", "Carbamazepine for focal seizures", "Vagus nerve stimulation as adjunct", "Ketogenic diet initiation"], "answer": "B", "answer_index": 1, "explanation": "In epileptic encephalopathy due to mutations like SCN8A, levetiracetam is preferred for its efficacy and lower risk of exacerbating behavioral issues in autism. Valproic acid can worsen aggression, while carbamazepine may aggravate generalized features. Dietary therapies are second-line.", "generator_model": "grok-4-0709", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: U (Underspecified). Verdict: Not uniquely determinable. The stem describes a child with autism, recurrent staring spells/facial twitching, multifocal EEG discharges, cortical dysplasia, and a de novo mutation, but does not specify the mutation or the precise epilepsy syndrome. The rationale assumes an SCN8A-related epileptic encephalopathy, but this is not stated. Without the specific genetic diagnosis, the first-line therapy is not uniquely determined from the vignette; levetiracetam (B) is a reasonable choice for many genetic epilepsies, but valproic acid (A) is also a standard broad-spectrum first-line option for multifocal epilepsies. The keyed answer relies on an unstated assumption. Main medical accuracy issue: The rationale's claim that valproic acid can worsen aggression in autism is an oversimplification; it is often used and can have variable behavioral effects. Minimal fix: Specify the genetic mutation (e.g., 'a de novo mutation in the SCN8A gene') in the stem to justify the targeted therapy recommendation.\",\n    \"logical_false_reason\": \"U\",\n    \"logical_validity\": false,\n    \"medical_accuracy_score\":  \"3\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (Underspecified). Verdict: Not uniquely determinable. The stem describes a child with autism, recurrent staring spells/facial twitching, multifocal EEG discharges, cortical dysplasia, and a de novo mutation, but does not specify the mutation or the precise epilepsy syndrome. The rationale assumes an SCN8A-related epileptic encephalopathy, but this is not stated. Without the specific genetic diagnosis, the first-line therapy is not uniquely determined from the vignette; levetiracetam (B) is a reasonable choice for many genetic epilepsies, but valproic acid (A) is also a standard broad-spectrum first-line option for multifocal epilepsies. The keyed answer relies on an unstated assumption. Main medical accuracy issue: The rationale's claim that valproic acid can worsen aggression in autism is an oversimplification; it is often used and can have variable behavioral effects. Minimal fix: Specify the genetic mutation (e.g., 'a de novo mutation in the SCN8A gene') in the stem to justify the targeted therapy recommendation.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed125", "question_id": "20251201T041413890Z_grok-4-0709_seed125-005", "question": "A 55-year-old man with Parkinson's disease develops sudden onset of dysarthria and hemiparesis. MRI shows acute infarction in the lenticulostriate territory, but vessel imaging is normal. Coagulation studies reveal an abnormality. What is the underlying mechanism?", "options": ["Cardioembolic stroke from atrial fibrillation", "Lacunar infarct due to small vessel disease", "Thrombotic stroke from antiphospholipid syndrome", "Vasculitis mimicking stroke", "Embolic stroke from levodopa-induced arrhythmia"], "answer": "C", "answer_index": 2, "explanation": "Antiphospholipid syndrome can cause thrombotic strokes in atypical territories without large vessel occlusion, especially with coagulation abnormalities. Lacunar infarcts are typically hypertensive, not matching this profile. Cardioembolism usually involves larger territories or arrhythmias, absent here.", "generator_model": "grok-4-0709", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K. Verdict on keyed answer: Miskeyed. Key stem clues: sudden onset, lenticulostriate territory infarct, normal vessels, coagulation abnormality. The most likely mechanism is a lacunar infarct from small vessel disease (hypertension, diabetes), as lenticulostriate arteries are classic small vessels. The coagulation abnormality is a distractor but does not override the anatomical localization. Option B is the single best answer. The keyed answer (C, antiphospholipid syndrome) is less likely as it typically causes larger vessel thrombosis or embolism, not isolated small deep infarcts with normal angiography. Main logical issue: miskeying. Main medical accuracy issue: overinterpreting a nonspecific coagulation abnormality as diagnostic for APS in this context. Minimal fix: Change key to B and adjust rationale to emphasize that lenticulostriate infarcts are most commonly lacunar, even with a coagulation study abnormality.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \"3\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K. Verdict on keyed answer: Miskeyed. Key stem clues: sudden onset, lenticulostriate territory infarct, normal vessels, coagulation abnormality. The most likely mechanism is a lacunar infarct from small vessel disease (hypertension, diabetes), as lenticulostriate arteries are classic small vessels. The coagulation abnormality is a distractor but does not override the anatomical localization. Option B is the single best answer. The keyed answer (C, antiphospholipid syndrome) is less likely as it typically causes larger vessel thrombosis or embolism, not isolated small deep infarcts with normal angiography. Main logical issue: miskeying. Main medical accuracy issue: overinterpreting a nonspecific coagulation abnormality as diagnostic for APS in this context. Minimal fix: Change key to B and adjust rationale to emphasize that lenticulostriate infarcts are most commonly lacunar, even with a coagulation study abnormality.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed125", "question_id": "20251201T041413890Z_grok-4-0709_seed125-006", "question": "In the ICU, a 70-year-old patient with septic shock from pneumonia remains hypotensive despite vasopressors and fluids. Adrenal function testing shows a blunted cortisol response, but random cortisol is normal. What is the next step in management?", "options": ["Initiate hydrocortisone replacement therapy", "Add fludrocortisone for mineralocorticoid support", "Perform cosyntropin stimulation test", "Switch to alternative vasopressor like vasopressin", "Administer ascorbic acid and thiamine"], "answer": "D", "answer_index": 3, "explanation": "Relative adrenal insufficiency in sepsis may not respond to steroids if cortisol is normal; switching to vasopressin addresses vasoplegia more effectively. Hydrocortisone is controversial without clear deficiency. Cosyntropin is already implied by blunted response.", "generator_model": "grok-4-0709", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: K. Verdict on keyed answer: Miskeyed. The stem describes septic shock with hypotension refractory to fluids and vasopressors, and adrenal testing showing a normal random cortisol but a blunted response to stimulation. In current critical care guidelines (e.g., Surviving Sepsis Campaign), the next step for refractory shock with suspected relative adrenal insufficiency is to initiate hydrocortisone therapy, not to switch vasopressors without that trial. Option A is the guideline-supported best answer. The keyed answer (D) is not the most defensible choice based on the clinical scenario and standard management. The item is logically valid in having a single best answer, but it is miskeyed. Main medical accuracy issue: recommending vasopressin switch over steroid trial contradicts standard sepsis management algorithms. Minimal fix: Change the correct answer key to A.\",\n    \"logical_false_reason\": \"K\",\n    \"logical_validity\": false,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 1006)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed125", "question_id": "20251201T041413890Z_grok-4-0709_seed125-007", "question": "A 38-year-old woman with chronic myeloid leukemia on dasatinib develops pleural effusions and fatigue. Cytogenetic analysis shows additional clonal evolution. What is the most appropriate therapeutic adjustment?", "options": ["Switch to imatinib to reduce pulmonary toxicity", "Add interferon-alpha for immunomodulation", "Initiate ponatinib for resistant mutations", "Dose reduce dasatinib and monitor", "Proceed to allogeneic stem cell transplant"], "answer": "C", "answer_index": 2, "explanation": "Clonal evolution in CML on dasatinib often indicates T315I mutation, for which ponatinib is effective despite pulmonary risks. Imatinib lacks potency against advanced disease. Transplant is considered but not first-line without failure of second-generation TKIs.", "generator_model": "grok-4-0709", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K. Verdict on keyed answer: Miskeyed. Key stem clues: chronic myeloid leukemia (CML) on dasatinib, development of pleural effusions and fatigue, cytogenetic analysis showing additional clonal evolution. The pleural effusion is a known adverse effect of dasatinib, and clonal evolution indicates disease progression/resistance. The logical issue is miskeying: the most appropriate initial therapeutic adjustment for a dasatinib-related adverse effect (pleural effusion) with clonal evolution is typically to switch to another second-generation TKI (like nilotinib or bosutinib) or dose reduce/manage the effusion, not immediately to ponatinib, which is reserved for specific high-risk mutations (e.g., T315I) not confirmed here. The stem is underspecified regarding the specific mutation, making ponatinib a premature leap. A unique best answer exists (likely D, dose reduction for toxicity while assessing resistance), but the provided key (C) is not it. Medical accuracy issue: ponatinib is not first-line for uncharacterized clonal evolution with concurrent drug toxicity. Minimal fix: Specify the mutation (e.g., 'shows T315I mutation') to justify ponatinib, or change the key to D.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \t\n  \"3\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K. Verdict on keyed answer: Miskeyed. Key stem clues: chronic myeloid leukemia (CML) on dasatinib, development of pleural effusions and fatigue, cytogenetic analysis showing additional clonal evolution. The pleural effusion is a known adverse effect of dasatinib, and clonal evolution indicates disease progression/resistance. The logical issue is miskeying: the most appropriate initial therapeutic adjustment for a dasatinib-related adverse effect (pleural effusion) with clonal evolution is typically to switch to another second-generation TKI (like nilotinib or bosutinib) or dose reduce/manage the effusion, not immediately to ponatinib, which is reserved for specific high-risk mutations (e.g., T315I) not confirmed here. The stem is underspecified regarding the specific mutation, making ponatinib a premature leap. A unique best answer exists (likely D, dose reduction for toxicity while assessing resistance), but the provided key (C) is not it. Medical accuracy issue: ponatinib is not first-line for uncharacterized clonal evolution with concurrent drug toxicity. Minimal fix: Specify the mutation (e.g., 'shows T315I mutation') to justify ponatinib, or change the key to D.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed125", "question_id": "20251201T041413890Z_grok-4-0709_seed125-008", "question": "A 35-year-old woman in the emergency department collapses after ingesting an unknown substance. She has bradycardia, hypotension, and miosis. Atropine provides partial response, but symptoms recur. What is the definitive antidote?", "options": ["Pralidoxime for organophosphate poisoning", "N-acetylcysteine for acetaminophen", "Flumazenil for benzodiazepine overdose", "Physostigmine for anticholinergic toxicity", "Hydroxocobalamin for cyanide"], "answer": "A", "answer_index": 0, "explanation": "This cholinergic toxidrome suggests organophosphate poisoning, where pralidoxime regenerates acetylcholinesterase after initial atropine. Atropine alone is insufficient for severe cases. Other antidotes target different mechanisms not fitting the presentation.", "generator_model": "grok-4-0709", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: acute collapse, unknown ingestion, bradycardia, hypotension, miosis (cholinergic toxidrome), and partial/transient response to atropine. This classic triad, especially with atropine's partial effect, strongly points to organophosphate/carbamate poisoning, where pralidoxime is the definitive enzyme-regenerating antidote. No logical issues; the stem supports a single best answer. Medical accuracy is sound, aligning with standard toxicology. The only minor nuance is that pralidoxime is most definitive for organophosphates, and its benefit in carbamates is debated, but the presentation is classic for organophosphate. Minimal fix: None required for a clear item; optionally specify 'organophosphate' in the stem to eliminate any remote ambiguity.\",\n    \"logical_false_reason\": \"T\",\n    \"logical_validity\": true,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 921)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed125", "question_id": "20251201T041413890Z_grok-4-0709_seed125-009", "question": "A 12-year-old girl with juvenile idiopathic arthritis on etanercept develops fever, rash, and lymphadenopathy. Serology is positive for a virus, but PCR on lymph node biopsy reveals clonal T-cell population. What is the most likely complication?", "options": ["Drug reaction with eosinophilia and systemic symptoms", "EBV-associated lymphoproliferative disorder", "Macrophage activation syndrome", "Secondary hemophagocytic lymphohistiocytosis", "TNF inhibitor-induced lymphoma"], "answer": "E", "answer_index": 4, "explanation": "TNF inhibitors like etanercept increase risk of T-cell lymphomas, especially with clonal populations on biopsy, beyond viral associations. EBV-LPD is B-cell predominant. MAS and HLH are cytokine-driven without clonality.", "generator_model": "grok-4-0709", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: JIA on etanercept, fever/rash/lymphadenopathy, positive viral serology, but lymph node biopsy shows clonal T-cell population. The keyed answer (E, TNF inhibitor-induced lymphoma) is a plausible consideration, but the stem's positive viral serology and clinical presentation (fever, rash, lymphadenopathy) are classic for a primary EBV infection. In a patient on immunosuppression, this creates a high risk for an EBV-associated lymphoproliferative disorder (LPD), which can be T-cell or NK-cell in a minority of cases. The clonality does not rule out an LPD; it supports a neoplastic process, which an EBV-LPD can be. Option B is equally, if not more, defensible given the viral serology context. Main logical issue: The stem provides data strongly supporting two distinct lymphoproliferative etiologies (viral vs. drug-induced), making a single best answer ambiguous. Main medical issue: Oversimplifies that EBV-LPD is exclusively B-cell; T-cell LPDs occur. Minimal fix: Specify the virus (e.g., 'EBV serology positive') and state PCR is for EBV-encoded RNA (EBER) to strongly anchor answer B, or remove the viral serology clue to anchor answer E.\",\n  \"logical_false_reason\": \"M\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \t\n  \"3\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: JIA on etanercept, fever/rash/lymphadenopathy, positive viral serology, but lymph node biopsy shows clonal T-cell population. The keyed answer (E, TNF inhibitor-induced lymphoma) is a plausible consideration, but the stem's positive viral serology and clinical presentation (fever, rash, lymphadenopathy) are classic for a primary EBV infection. In a patient on immunosuppression, this creates a high risk for an EBV-associated lymphoproliferative disorder (LPD), which can be T-cell or NK-cell in a minority of cases. The clonality does not rule out an LPD; it supports a neoplastic process, which an EBV-LPD can be. Option B is equally, if not more, defensible given the viral serology context. Main logical issue: The stem provides data strongly supporting two distinct lymphoproliferative etiologies (viral vs. drug-induced), making a single best answer ambiguous. Main medical issue: Oversimplifies that EBV-LPD is exclusively B-cell; T-cell LPDs occur. Minimal fix: Specify the virus (e.g., 'EBV serology positive') and state PCR is for EBV-encoded RNA (EBER) to strongly anchor answer B, or remove the viral serology clue to anchor answer E.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed125", "question_id": "20251201T041413890Z_grok-4-0709_seed125-010", "question": "A 68-year-old man with amyotrophic lateral sclerosis presents with progressive dysphagia and aspiration. Videofluoroscopy shows pharyngeal weakness. Non-invasive ventilation is in use. What is the most appropriate intervention?", "options": ["Percutaneous endoscopic gastrostomy placement", "Botulinum toxin injection into cricopharyngeus", "Tracheostomy for airway protection", "Speech therapy with swallowing exercises", "Pharmacologic enhancement with edrophonium"], "answer": "B", "answer_index": 1, "explanation": "In ALS with cricopharyngeal dysfunction causing dysphagia, botulinum toxin relaxes the muscle to improve swallowing, a targeted approach before invasive feeding. PEG is for nutrition but not dysphagia mechanism. Tracheostomy addresses ventilation, not swallowing.", "generator_model": "grok-4-0709", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: ALS with progressive dysphagia, aspiration, pharyngeal weakness on videofluoroscopy, NIV in use. The most appropriate intervention for dysphagia with aspiration in advanced ALS is typically percutaneous endoscopic gastrostomy (PEG) for long-term enteral nutrition and to reduce aspiration risk, not a temporizing botulinum toxin injection into a specific muscle. The keyed answer (B) is not the standard best answer. Main logical issue: A unique best answer (A) exists, but the provided key is incorrect. Main medical accuracy issue: Botulinum toxin is not first-line for ALS dysphagia; PEG is standard for nutrition and aspiration prevention. Minimal fix: Change the correct answer key to A (Percutaneous endoscopic gastrostomy placement).\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \"2\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: ALS with progressive dysphagia, aspiration, pharyngeal weakness on videofluoroscopy, NIV in use. The most appropriate intervention for dysphagia with aspiration in advanced ALS is typically percutaneous endoscopic gastrostomy (PEG) for long-term enteral nutrition and to reduce aspiration risk, not a temporizing botulinum toxin injection into a specific muscle. The keyed answer (B) is not the standard best answer. Main logical issue: A unique best answer (A) exists, but the provided key is incorrect. Main medical accuracy issue: Botulinum toxin is not first-line for ALS dysphagia; PEG is standard for nutrition and aspiration prevention. Minimal fix: Change the correct answer key to A (Percutaneous endoscopic gastrostomy placement).", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}]